Experimental Gene Therapy Showed Promising Safety and Efficacy in Primate Study of Late-Infantile Batten Disease
source: shutterstock.com

Experimental Gene Therapy Showed Promising Safety and Efficacy in Primate Study of Late-Infantile Batten Disease

Children with late-infantile onset Batten disease (CLN2) may be treated with an enzyme replacement therapy (ERT). However, this therapy cannot reverse the damage or progression children have already experienced. Researchers…

Continue Reading Experimental Gene Therapy Showed Promising Safety and Efficacy in Primate Study of Late-Infantile Batten Disease
Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects
source: pixabay.com

Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects

People living with blood disorders like sickle cell disease or thalassemia will now have access to a new blood test that will reduce transfusion side effects. England’s National Health Service…

Continue Reading Thalassemia and Sickle Cell Patients in the UK Gain Access to Blood Transfusion Test to Reduce Side Effects